Referenze

1. Patent on the polymerisation of the low-and high-molecular-weight plysaccharides US20120295870.

2. Raspaldo H., J Cosmet and Laser Ther. 2008; 10:134-142

3. Eccleston D, Murphy DK. Clin Cosmet Investing Dermatol, 2012; 5:167-172

4. Philipp-Dormston 2014 Apr EO - Hyaluronic AcidLidocaine

5. Belhaouari L. et al. Poster presented at 8th Anti-Aging Medicine World Conference, 8-10 April 2010, Monaco

6. Levy p, MD et al. Comparison of Injection Comfort and Ease with Juvéderm Ultra3 and Surgiderm 30 X

7. Wolfgang G. Philipp-Dormston et al. Poster presented at 8th European Master in Aesthetic and Anti-Aging Medicine (EMAA). 12-14 October 2012 Paris, France

8. Allergan Data on File

9. Allergan, dati di archivio. Internal communication. Number of Patients involved in Clinical Trials

10. Allergan, dati di archivio. Internal communication. Number of Units Sold

11. Allergan, dati di archivio. Internal communication. Total R&D Investment

12. Carruthers J, Fagien S, Matarosso S, and the Botox Consensus Group. Consensus recommendations on the use of Botulinum Toxin Type A infacial aesthetics. Plastic and Reconstructive Surgery 2004;114(suppl6):1S-21S.

13. Dormston W. Poster presented ad 15th International Master Course on Aging Skin (IMCAS), 31 January-3 February 2013 Paris, France

14. Voluma, Volift, Volbella DFU